Stock Track | BeiGene Shares Soar 5.03% Following Strong Q3 Financial Results and Turnaround to Profitability

Stock Track11-12

BeiGene Ltd. (ONC) saw its stock price surge 5.03% in pre-market trading on Wednesday, following the release of its impressive third-quarter financial results for 2025. The biotechnology company's performance marked a significant turnaround, transitioning from losses to substantial profits.

According to the financial report, BeiGene's revenue for the first three quarters of 2025 reached RMB27.595 billion, representing a robust year-on-year growth of 44.2%. More notably, the company reported a net profit attributable to shareholders of RMB1.139 billion, successfully reversing the losses incurred during the same period last year. The non-GAAP net profit stood at RMB969 million, further underlining the company's financial recovery.

Investors were particularly encouraged by BeiGene's basic earnings per share of RMB0.81. The company attributed its improved performance to strong product revenue growth and enhanced operational efficiency through effective cost management strategies. This positive financial outlook has clearly resonated with the market, driving the significant uptick in BeiGene's stock price as traders react to the company's newfound profitability and growth prospects.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/1142755606?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-11-12 22:56","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1142755606","market":"nz","top_or_hot":-1,"title":"Stock Track | BeiGene Shares Soar 5.03% Following Strong Q3 Financial Results and Turnaround to Profitability","media":"Stock Track","content":"<p>BeiGene Ltd. (ONC) saw its stock price surge 5.03% in pre-market trading on Wednesday, following the release of its impressive third-quarter financial results for 2025. The biotechnology company's performance marked a significant turnaround, transitioning from losses to substantial profits.</p>\n\n<p>According to the financial report, BeiGene's revenue for the first three quarters of 2025 reached RMB27.595 billion, representing a robust year-on-year growth of 44.2%. More notably, the company reported a net profit attributable to shareholders of RMB1.139 billion, successfully reversing the losses incurred during the same period last year. The non-GAAP net profit stood at RMB969 million, further underlining the company's financial recovery.</p>\n\n<p>Investors were particularly encouraged by BeiGene's basic earnings per share of RMB0.81. The company attributed its improved performance to strong product revenue growth and enhanced operational efficiency through effective cost management strategies. This positive financial outlook has clearly resonated with the market, driving the significant uptick in BeiGene's stock price as traders react to the company's newfound profitability and growth prospects.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | BeiGene Shares Soar 5.03% Following Strong Q3 Financial Results and Turnaround to Profitability</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | BeiGene Shares Soar 5.03% Following Strong Q3 Financial Results and Turnaround to Profitability\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-11-12 22:56</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>BeiGene Ltd. (ONC) saw its stock price surge 5.03% in pre-market trading on Wednesday, following the release of its impressive third-quarter financial results for 2025. The biotechnology company's performance marked a significant turnaround, transitioning from losses to substantial profits.</p>\n\n<p>According to the financial report, BeiGene's revenue for the first three quarters of 2025 reached RMB27.595 billion, representing a robust year-on-year growth of 44.2%. More notably, the company reported a net profit attributable to shareholders of RMB1.139 billion, successfully reversing the losses incurred during the same period last year. The non-GAAP net profit stood at RMB969 million, further underlining the company's financial recovery.</p>\n\n<p>Investors were particularly encouraged by BeiGene's basic earnings per share of RMB0.81. The company attributed its improved performance to strong product revenue growth and enhanced operational efficiency through effective cost management strategies. This positive financial outlook has clearly resonated with the market, driving the significant uptick in BeiGene's stock price as traders react to the company's newfound profitability and growth prospects.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"ONC","symbol_name":"百济神州","start_time":0,"source_url":"","article_id":"1142755606","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1142755606","pubTimestamp":1762959402,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"BeiGene Ltd. (ONC) saw its stock price surge 5.03% in pre-market trading on Wednesday, following the release of its impressive third-quarter financial results for 2025. The biotechnology company's...","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"ONC":"百济神州"},"translate_title":"个股追踪|第三季度财报强劲扭亏为盈百济神州股价飙升5.03%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"ONC":1},"content_text":"BeiGene Ltd. (ONC) saw its stock price surge 5.03% in pre-market trading on Wednesday, following the release of its impressive third-quarter financial results for 2025. The biotechnology company's performance marked a significant turnaround, transitioning from losses to substantial profits.\nAccording to the financial report, BeiGene's revenue for the first three quarters of 2025 reached RMB27.595 billion, representing a robust year-on-year growth of 44.2%. More notably, the company reported a net profit attributable to shareholders of RMB1.139 billion, successfully reversing the losses incurred during the same period last year. The non-GAAP net profit stood at RMB969 million, further underlining the company's financial recovery.\nInvestors were particularly encouraged by BeiGene's basic earnings per share of RMB0.81. The company attributed its improved performance to strong product revenue growth and enhanced operational efficiency through effective cost management strategies. This positive financial outlook has clearly resonated with the market, driving the significant uptick in BeiGene's stock price as traders react to the company's newfound profitability and growth prospects.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"2","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.9","shortVersion":"4.35.9","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/1142755606","isCrawlerRequest":true}